AstraZeneca Invests Rs 1.76 Billion to Expand Chennai Centre
ECONOMY & POLICY

AstraZeneca Invests Rs 1.76 Billion to Expand Chennai Centre

Global pharmaceutical major AstraZeneca on Saturday announced an investment of Rs 1.76 billion in India to expand capabilities and infrastructure at its Global Innovation & Technology Centre (GITC) in Chennai.
This new investment, the third in the past two years in India, will enhance the GITC’s capacity to reinforce its position as a leader in healthcare innovation both globally and within the country, AstraZeneca stated.
“This new investment reflects our ongoing mission to improve patient lives by embedding cutting-edge technologies into every aspect of our work. Chennai continues to evolve as a vital innovation hub, and our continued growth here demonstrates the state’s boundless potential,” said Mr Siva Padmanabhan, Managing Director of AstraZeneca India Pvt Ltd.
The investment will support the expansion of AstraZeneca’s world-class technology and innovation teams, including experts in artificial intelligence, data analytics, machine learning, data science and supply chain analytics, all aimed at transforming healthcare outcomes.
Furthermore, the initiative will accelerate the development of next-generation medicines, support digital and data-driven solutions, and foster future-ready healthcare ecosystems.
Quoting Tamil Nadu Chief Minister MK Stalin, the statement said, “This additional investment in Chennai is a testament to the state’s reputation as a centre of excellence for global innovation.” Mr Stalin added that the partnership would create skilled opportunities, promote knowledge exchange, and strengthen Tamil Nadu’s position as a preferred destination for forward-looking industries.
In addition to its innovative portfolio in specialist disease areas such as oncology, cardiovascular conditions, respiratory illnesses and rare diseases, AstraZeneca noted its strong presence in technology, global business services, and research and development in India. Including the GITC, the company employs more than 5,000 people in the country.

Global pharmaceutical major AstraZeneca on Saturday announced an investment of Rs 1.76 billion in India to expand capabilities and infrastructure at its Global Innovation & Technology Centre (GITC) in Chennai.This new investment, the third in the past two years in India, will enhance the GITC’s capacity to reinforce its position as a leader in healthcare innovation both globally and within the country, AstraZeneca stated.“This new investment reflects our ongoing mission to improve patient lives by embedding cutting-edge technologies into every aspect of our work. Chennai continues to evolve as a vital innovation hub, and our continued growth here demonstrates the state’s boundless potential,” said Mr Siva Padmanabhan, Managing Director of AstraZeneca India Pvt Ltd.The investment will support the expansion of AstraZeneca’s world-class technology and innovation teams, including experts in artificial intelligence, data analytics, machine learning, data science and supply chain analytics, all aimed at transforming healthcare outcomes.Furthermore, the initiative will accelerate the development of next-generation medicines, support digital and data-driven solutions, and foster future-ready healthcare ecosystems.Quoting Tamil Nadu Chief Minister MK Stalin, the statement said, “This additional investment in Chennai is a testament to the state’s reputation as a centre of excellence for global innovation.” Mr Stalin added that the partnership would create skilled opportunities, promote knowledge exchange, and strengthen Tamil Nadu’s position as a preferred destination for forward-looking industries.In addition to its innovative portfolio in specialist disease areas such as oncology, cardiovascular conditions, respiratory illnesses and rare diseases, AstraZeneca noted its strong presence in technology, global business services, and research and development in India. Including the GITC, the company employs more than 5,000 people in the country.

Next Story
Infrastructure Energy

Vedanta Aluminium Uses 1.57 bn Units of Green Energy in FY25

Vedanta Aluminium, India’s largest aluminium producer, recently reported consumption of 1.57 billion units of renewable energy in FY25, marking a significant milestone in its 2030 decarbonisation roadmap. The company also achieved an 8.96 per cent reduction in greenhouse gas (GHG) emissions intensity compared to FY21, reinforcing its leadership in India’s low-carbon manufacturing transition. During FY25, Vedanta Aluminium expanded its renewable energy portfolio through long-term power purchase agreements, strengthening its strategy to source nearly 1,500 MW of renewable power over the lon..

Next Story
Real Estate

Oberoi Group to Develop Luxury Resort at Makaibari Tea Estate

EIH Limited, the flagship company of The Oberoi Group, has announced the signing of a management agreement to develop an Oberoi luxury resort at the iconic Makaibari Tea Estate in Darjeeling. The project marks a key milestone in the Group’s long-term strategy of creating distinctive hospitality experiences in rare and environmentally significant locations. Established in 1859, Makaibari is one of the world’s oldest tea estates and is globally recognised for its Himalayan landscape, primary forests and exceptional biodiversity. Spread across 1,236 acres, the estate houses one of the world..

Next Story
Real Estate

GHV Infra Secures Rs 1.09 Bn EPC Order in Jamshedpur

GHV Infra Projects Ltd, a fast-growing EPC company in India’s infrastructure and construction sector, has recently secured a Rs 1.09 billion work order in Jamshedpur, Jharkhand. Awarded by a reputed group entity, the contract covers end-to-end civil construction, mechanical, electrical and plumbing (MEP) systems, along with high-quality finishing works for a large building development. The project will be executed over a 30-month period, with defined benchmarks for quality, safety and timely delivery. The order strengthens GHV Infra’s footprint in Jamshedpur, a key industrial hub known fo..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Open In App